Get in Touch with Us

For general inquiries please email us at info@everyonemedicines.com

Please refrain from sending any sensitive patient information via email. If you need to share such details, use the secure form provided below.

Patient Inquiries

EveryONE Medicines is developing individualized antisense oligonucleotides for children with severe CNS conditions resulting from uniquely rare genetic mutations.

We are currently focused on the clinical stage development of multiple ASOs in countries outside of the United States. We continue to assess the opportunity for clinical stage development of ASOs in the US.

To assess whether an individual meets the criteria for development of an individualized therapy, please submit the following information.